BURNABY, Canada, December 17, 2015 /PRNewswire/ --
Growing incidence of hospital-acquired infections and stringent government policies to drive the United States hospital-acquired infections prevention market through 2020
According to recently published Pharmaion report, "United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020", hospital-acquired infections prevention market in the United States is projected to grow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention market can be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseases among geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospital-acquired infections, under the Deficit Regulation Act, 2005, is also anticipated to drive demand for hospital-acquired infections prevention market in the United States during 2015 - 2020.
On the basis of prevention type, the market has been segmented into two categories, namely, sterilization and disinfection. Among these categories, sterilization segment dominated the United States hospital-acquired infections prevention market in 2014, and is anticipated to continue its dominance during forecast period on account of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devices used in diagnostic and treatment procedures. South region accounted for the largest share in the United States hospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions.
"With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupled with growing adoption of gas plasma sterilization technology, the market for hospital-acquired infections prevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover, Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services (HHS) developed the "National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination" in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings, including acute care hospitals, ambulatory surgical centers, end-stage renal disease facilities and long-term care facilities." said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global pharmaceutical and healthcare consulting firm.
"United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020" has evaluated the future growth potential of the United States hospital-acquired infections prevention market and provides statistics and information on market structure, industry behavior and trends. The report is intended to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes emerging trends along with essential drivers, challenges and opportunities available in United States hospital-acquired infections prevention market.
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion's clients lead rather than follow market trends. Pharmaion has developed a proprietary database which focuses on identifying the unexplored opportunities in Healthcare and Pharmaceutical industry.
Contact Phone- +1 646 360 1656